MPH Health Care AG
MPH Health Care AG, first quarter 2020: Preliminary IFRS result, equity (Net Asset Value) 184.17 million euros, or 4.30 euros per share.

First quarter 2020: Preliminary IFRS result, equity (Net Asset Value) 184.17 million euros, or 4.30 euros per share.

Berlin, 29 May 2020: MPH Health Care AG (“MPH”) announces its preliminary IFRS results for the first quarter of 2020. Accordingly, the preliminary IFRS equity as of 31 March 2020 amounts to EUR 184.17 million (as of 31 December 2019: EUR 271.64 million).

The reason for the decrease in equity is the fair value measurement of the share prices of the investments at the reporting date of 31 March 2020 compared to the share prices at 31 December 2019, which is mainly influenced by the general negative development on the global stock markets in the wake of the corona pandemic in the first quarter of 2020..

The Net Asset Value (NAV) decreased year-on-year from EUR 6.15 to EUR 4.30 per share, but is still well above the Xetra closing price of EUR 2.74 per share on March 31, 2020.

“The further development of our listed shareholdings M1 Kliniken AG, HAEMATO AG and CR Capital Real Estate AG in 2020 is, inter alia, marked by the general economic development in the context of the corona crisis as well as possible catch-up effects from the second half of 2020, provided that there is further easing and a “normalization” of business life. We are already seeing the first signs of this.

Our investment M1 Kliniken AG has now reopened almost all its facilities on the basis of a strict security and hygiene concept. Despite extended treatment intervals, a sales level comparable to the “pre-corona business volume” was already achieved in the first week. In addition, the clinics are almost completely booked out for a period of several weeks. M1 therefore assumes that the closure period and other effects of the corona pandemic will not have a long-term and sustainable impact on the Group’s business model.

Our investment HAEMATO AG continues to systematically benefit from the growth of the health care and pharmaceutical market in Germany and was able to increase sales in the first quarter of 2020 by about 25 % compared to the previous year. As part of the renewal of the product portfolio, HAEMATO was able to place 38 medical drugs on the market during this period for newly granted approvals (i.e. products)..

Our third listed investment, CR Capital Real Estate AG, has so far not experienced any restrictions due to the corona pandemic and continues to record a high demand for affordable housing”, says Patrick Brenske, member of the Managing Board of MPH.

The Annual Report 2019 of MPH Health Care AG was published on the website on May 27, 2020. The net asset value could be increased in the financial year 2019 from 6.29 euros to 6.34 euros per share. The IFRS consolidated net profit in the financial year 2019 amounted to EUR 11.08 million (previous year EUR 37.03 million).

About MPH Health Care AG:
MPH AG is an investment company with a strategic focus on the purchase, development and sale of companies and company shares, especially in growth segments of the health care market. This includes both insurance-financed and privately financed segments. However, MPH also exploits potentials outside the healthcare market from high-growth and high-yield sectors.

MPH Health Care AG is listed on the Basic Board (Open Market) of the Frankfurt Stock Exchange.

Key figures of the MPH Health Care AG share:
Subscribed capital: EUR 42,813,842
Listed class of shares: ordinary bearer shares
ISIN: EN000A0L1H32
WKN: A0L1H3
Ticker symbol: 93M